Загрузка...
Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome
BACKGROUND: The clustering of cardiovascular risk factors is termed the metabolic syndrome (MS), which strongly predicts the risk of diabetes and cardiovascular disease (CVD). Adipokines may contribute to the development of obesity and insulin resistance and may be a causal link between MS, diabetes...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263179/ https://ncbi.nlm.nih.gov/pubmed/22276262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.91206 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|